Juvenile respiratory papillomatosis: Risk factors for severity

Journal of Medical Virology

Volumn 85, Issue 8, 2013, Pages 1447-1458

  Rodier, Caroline ^a,b,c   Lapointe, Annie ^b   Coutlée, François ^d   Mayrand, Marie Hélène ^a,d   Dal Soglio, Dorothée ^b   Roger, Michel ^d   Trottier, Helen ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c Merck Canada Inc   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Human papillomavirus; Papillomatosis; Risk; Severity

Indexed keywords

HLA ANTIGEN CLASS 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONDYLOMA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENOTYPE; HLA SYSTEM; HUMAN; JUVENILE; MALE; PAPILLOMATOSIS; PRESCHOOL CHILD; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; VIRUS LOAD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SALIVA; VIRAL LOAD;

HUMAN PAPILLOMAVIRUS;

EID: 84879154464     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23615     Document Type: Article

References (40)

1. Abramson AL, Steinberg BM. Winkler B. 1987. Laryngeal papillomatosis: Clinical, histopathologic and molecular studies. Laryngoscope 97:678-685.
2. Aho J, Kornegay JR, Healey S, Roger M, Dion F, Gaudreault D, Shepard AP, Franco EL, Coutlee F. 2004. Evaluation of a convenient enzyme immunoassay to assess the quality of genital specimens submitted for the detection of human papillomavirus DNA by consensus PCR. J Clin Virol 29:127-133.
3. Armstrong LR, Derkay CS, Reeves WC. 1999. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 125:743-748.
4. Bishai D, Kashima H. Shah K. 2000. The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 126:935-939.
5. Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Shikowitz MJ, Gjertson DW, Reed, EF. 2004. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol 65:773-782.
6. Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Gjertson DW, Reed EF, Rajalingam R. 2009. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol 71:212-219.
7. Buchinsky FJ, Donfack J, Derkay CS, Choi SS, Conley SF, Myer CM, McClay JE, Campisi P, Wiatrak BJ, Sobol SE, Schweinfurth JM, Tsuji DH, Hu FZ, Rockette HE, Ehrlich GD, Post JC. 2008. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS ONE 3:e2263.
8. Campisi P, Hawkes M, Simpson K. 2010. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope 120:1233-1245.
9. Carvalho CM, Huot L, Charlois AL, Khalfallah SA, Chapuis F, Froehlich P. 2009. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol 129:462-470.
10. Che YM, Wang JB, Liu YH. 2005. Correlation between deoxyribonucleic acid loads of human papillomavirus and recurrence of condylomata acuminata. Int J STD AIDS 16:605-607.
11. Cook JR, Hill DA, Humphrey PA, Pfeifer JD, El-Mofty SK. 2000. Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: Emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol 13:914-918.
12. Coutlee F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vezina S, Cote P, Macleod J, Voyer H, Forest P, Walmsley S, Franco E. 2006. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J Clin Microbiol 44:1998-2006.
13. Coutlee F, Trottier H, Gagnon S, Koushik A, Richardson H, Roger M, Ferenczy AS, Franco EL. 2009. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. J Clin Virol 45:96-99.
14. Derkay CS. 1995. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 121:1386-1391.
15. Derkay CS. 2001. Recurrent respiratory papillomatosis. Laryngoscope 111:57-69.
16. Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD. 1998. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 108:935-937.
17. Donne AJ, Hampson L, Homer JJ, Hampson IN. 2010. The role of HPV type in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 74:7-14.
18. Draganov P, Todorov S, Todorov I, Karchev T, Kalvatchev Z. 2006. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol 70:469-473.
19. Feoli-Fonseca JC, Oligny LL, Filion M, Brochu P, Simard P, Russ PA, Yotov WV. 1998. A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Diagn Mol Pathol 7:317-323.
20. Gabbott M, Cossart YE, Kan A, Konopka M, Chan R, Rose, BR. 1997. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 35:3098-3103.
21. Gerein V, Rastorguev E, Gerein J, Draf W, Schirren J. 2005. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 Years experience. Otolaryngol Head Neck Surg 132:392-394.
22. Gohy L, Gorska I, Rouleau D, Ghattas G, Pokomandy A, Vezina S, Cote P, Macleod J, Allaire G, Hadjeres R, Kornegay JR, Franco E, Coutlee F. 2008. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr 49:32-39.
23. Hester RP, Derkay CS, Burke BL, Lawson ML. 2003. Reliability of a staging assessment system for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 67:505-509.
24. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Matlashewski G, Roger M, Ferenczy AS, Franco EL, Coutlee F. 2007. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix. Int J Cancer 121:2674-2681.
25. Koushik A, Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlee F, Franco EL. 2005. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detect Prev 29:307-316.
26. Lefevre J, Hankins C, Pourreaux K, Voyer H, Coutlee F. 2003. Real-time PCR assays using internal controls for quantitation of HPV-16 and beta-globin DNA in cervicovaginal lavages. J Virol Methods 114:135-144.
27. Lefevre J, Hankins C, Pourreaux K, Voyer H, Coutlee F. 2004. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J Med Virol 72:132-137.
28. Leung R, Hawkes M, Campisi P. 2007. Severity of juvenile onset recurrent respiratory papillomatosis is not associated with socioeconomic status in a setting of universal health care. Int J Pediatr Otorhinolaryngol 71:965-972.
29. Maloney EM, Unger ER, Tucker RA, Swan D, Karem K, Todd NW, Reeves WC. 2006. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 132:711-715.
30. Parham P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201-214.
31. Pou AM, Rimell FL, Jordan JA, Shoemaker DL, Johnson JT, Barua P, Post JC, Ehrlich GD. 1995. Adult respiratory papillomatosis: Human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 104:758-762.
32. Rabah R, Lancaster WD, Thomas R, Gregoire L. 2001. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 4:68-72.
33. Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A, Unger ER. 2003. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 129:976-982.
34. Rimell FL, Shoemaker DL, Pou AM, Jordan JA, Post JC, Ehrlich GD. 1997. Pediatric respiratory papillomatosis: Prognostic role of viral typing and cofactors. Laryngoscope 107:915-918.
35. Saumet L, Damay A, Jeziorski E, Cartier C, Rouleau C, Margueritte G, Rodiere M, Segondy M. 2010. Bronchopulmonary squamous cell carcinoma associated with HPV 11 in a 15-year-old girl with a history of severe recurrent respiratory papillomatosis: A case report. Arch Pediatr 18:754-757.
36. Scurry WC, Jr., McGinn JD. 2008. Recurrent respiratory papillomatosis in pregnancy: A case of emergent airway management. Ear Nose Throat J 87:E8-E11.
37. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah, KV. 2003. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101:645-652.
38. Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah, KV. 2004. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg 130:711-716.
39. Smith EM, Johnson SR, Cripe TP, Pignatari S, Turek L. 1991. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol 100:479-483.
40. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. 2004. Recurrent respiratory papillomatosis: A longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114:1-23.